Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Vios Monitoring System™ Model 2050

K-Number: K172586 · 2018-06-22

ApplicantVios Medical, Inc.
Decision Date2018-06-22
Product CodeDRT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Vios Monitoring System™ Model 2050 is a medical device manufactured by Vios Medical, Inc.. It received FDA 510(k) clearance on 2018-06-22 under approval number K172586. The device is classified under product code DRT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Vios Monitoring System™ Model 2050?

Vios Monitoring System™ Model 2050 is a medical device that received FDA 510(k) clearance on 2018-06-22. It is manufactured by Vios Medical, Inc.. The 510(k) number is K172586.

When was Vios Monitoring System™ Model 2050 approved by the FDA?

Vios Monitoring System™ Model 2050 received FDA 510(k) clearance on 2018-06-22, under approval number K172586.

What company makes Vios Monitoring System™ Model 2050?

Vios Monitoring System™ Model 2050 is manufactured by Vios Medical, Inc..

What is the FDA product code for Vios Monitoring System™ Model 2050?

The FDA product code for Vios Monitoring System™ Model 2050 is DRT.

Related Clinical Trials

NCT07092761 Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT03053791 Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait RECRUITING NCT07614581 Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD: A Signal Characterisation Pilot Study NOT_YET_RECRUITING NCT03262415 PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor COMPLETED NCT07611721 Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy. RECRUITING

Related PubMed Literature

PMID: 42174947 Aligning AI-Native 6G Healthcare Systems with EU Ethical and Legal Frameworks. Studies in health technology and informatics (2026) PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 41915420 Analysis Model for Infant Incubator Adverse Events Using Retrieval-Augmented Generation Combined With Dual-Adapter Fine-Tuning: Development and Evaluation Study. JMIR medical informatics (2026) PMID: 41619565 Integration of materiovigilance in Unani medicine: A step towards patient safety. Journal of Ayurveda and integrative medicine (2026)

Other Devices by Vios Medical, Inc.

K173107Vios Central Station Monitor Software, Vios Central Server Software

Related Devices (Code: DRT)

K151781Cardiac Trigger Monitor, Cardiac & Regulatory Synchronization MonitorIvy Biomedical Systems, Inc. K170828Cardiac Trigger MonitorIvy Biomedical Systems, Inc. K181165Philips wearable biosensor-G5 SolutionConnected Sensing- A Division of Philips Medical Systems K202138Cardiac Trigger MonitorIvy Biomedical Systems, Inc. K202464Vital Sign Monitoring Sensor (Model :XK300)Xandar Kardian, Inc. K212143Neteera 130H/131H Vital Sign Monitoring SensorNeteera Technologies , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑